Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Antibiotic Injection Recalled
04/28/2022
Mylan Pharmaceuticals Inc is voluntarily recalling 33,893 vials of a prescription antibiotic.
Mylan Pharmaceuticals Inc is voluntarily recalling 33,893 vials of a prescription antibiotic.
Mylan Pharmaceuticals Inc is...
04/28/2022
Pharmacy Learning Network
News
Class I, II Recalls for Hand Sanitizer
04/28/2022
Artnaturals hand sanitizer is under Class I and II recalls for being contaminated with benzene, acetaldehyde, and acetal.
Artnaturals hand sanitizer is under Class I and II recalls for being contaminated with benzene, acetaldehyde, and acetal.
Artnaturals hand sanitizer is...
04/28/2022
Pharmacy Learning Network

Advertisement

News
Administrative Barriers Limit Pharmacist-Administered Vaccination Rates
04/26/2022
Pharmacists are both accessible and cost-effective providers of vaccinations; however, recent data show administrative factors are thwarting efforts to improve vaccination rates.
Pharmacists are both accessible and cost-effective providers of vaccinations; however, recent data show administrative factors are thwarting efforts to improve vaccination rates.
Pharmacists are both accessible...
04/26/2022
Pharmacy Learning Network
News
Medication Management Service Opportunity Benefits Children With Medical Complexity
04/20/2022
Researchers examined the potential benefit of a pharmacist-guided pediatric medication therapy management service for children with medical complexity.
Researchers examined the potential benefit of a pharmacist-guided pediatric medication therapy management service for children with medical complexity.
Researchers examined the...
04/20/2022
Pharmacy Learning Network
News
High Antibiotic Intake Linked to Cancer Development
04/20/2022
Findings show the likelihood of cancer development is higher among patients with a history of high consumption of antibiotics. 
Findings show the likelihood of cancer development is higher among patients with a history of high consumption of antibiotics. 
Findings show the likelihood of...
04/20/2022
Pharmacy Learning Network

Advertisement

News
Class I Recall for Chemotherapy Drug
04/20/2022
A Class I recall has been issued for a chemotherapy drug due to the presence of silica and iron oxide particulate matter.
A Class I recall has been issued for a chemotherapy drug due to the presence of silica and iron oxide particulate matter.
A Class I recall has been issued...
04/20/2022
Pharmacy Learning Network
News
Pharmacists Educate Patients on Partial Fill Option for Acute Opioid Prescriptions
04/19/2022
More acute opioid prescriptions were partially filled instead of fully filled after community pharmacists offered patients the option, findings showed.
More acute opioid prescriptions were partially filled instead of fully filled after community pharmacists offered patients the option, findings showed.
More acute opioid prescriptions...
04/19/2022
Pharmacy Learning Network
News
Sedative Injection Recalled
04/13/2022
Vitae Enim Vitae Scientific Inc is voluntarily recalling numerous lots of sedative injections.
Vitae Enim Vitae Scientific Inc is voluntarily recalling numerous lots of sedative injections.
Vitae Enim Vitae Scientific Inc...
04/13/2022
Pharmacy Learning Network

Advertisement

News
Potential Clogging of Anaphylaxis Med Prompts Class I Recall
04/13/2022
Prefilled syringes containing epinephrine are under a Class I recall because of potential clogging of the needle, preventing the medication from dispensing.
Prefilled syringes containing epinephrine are under a Class I recall because of potential clogging of the needle, preventing the medication from dispensing.
Prefilled syringes containing...
04/13/2022
Pharmacy Learning Network
News
Hypertension Drugs Recalled
04/13/2022
A Class II recall has been issued for multiple lots of hypertension drugs due to the presence of a nitrosamine impurity.
A Class II recall has been issued for multiple lots of hypertension drugs due to the presence of a nitrosamine impurity.
A Class II recall has been...
04/13/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use